Callahan Advisors LLC Sells 172 Shares of Danaher Co. (NYSE:DHR)

Callahan Advisors LLC decreased its holdings in shares of Danaher Co. (NYSE:DHR) by 1.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 12,708 shares of the conglomerate’s stock after selling 172 shares during the quarter. Callahan Advisors LLC’s holdings in Danaher were worth $2,917,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC bought a new stake in Danaher during the 4th quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher during the 4th quarter valued at approximately $31,000. Golden State Wealth Management LLC bought a new stake in Danaher during the 4th quarter valued at approximately $31,000. Teachers Insurance & Annuity Association of America bought a new stake in shares of Danaher in the 3rd quarter worth approximately $39,000. Finally, MidAtlantic Capital Management Inc. bought a new stake in shares of Danaher in the 3rd quarter worth approximately $40,000. Institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on DHR shares. Barclays reduced their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. UBS Group reduced their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research report on Friday, December 13th. TD Cowen raised their price objective on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 price objective (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Stock Performance

DHR stock opened at $206.66 on Tuesday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The business’s 50-day moving average price is $228.95 and its two-hundred day moving average price is $248.61. The firm has a market cap of $149.26 billion, a PE ratio of 39.14, a P/E/G ratio of 2.68 and a beta of 0.83. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the firm earned $2.09 EPS. As a group, research analysts forecast that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.